shRNA-Mediated XRCC2 Gene Knockdown Efficiently Sensitizes Colon Tumor Cells to X-ray Irradiation in Vitro and in Vivo
Open Access
- 29 January 2014
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 15 (2) , 2157-2171
Abstract
Colon cancer is one of the most common tumors of the digestive tract. Resistance to ionizing radiation (IR) decreased therapeutic efficiency in these patients’ radiotherapy. XRCC2 is the key protein of DNA homologous recombination repair, and its high expression is associated with enhanced resistance to DNA damage induced by IR. Here, we investigated the effect of XRCC2 silencing on colon tumor cells’ growth and sensitivity to X-radiation in vitro and in vivo. Colon tumor cells (T84 cell line) were cultivated in vitro and tumors originated from the cell line were propagated as xenografts in nude mice. The suppression of XRCC2 expression was achieved by using vector-based short hairpin RNA (shRNA) in T84 cells. We found that the knockdown of XRCC2 expression effectively decreased T84 cellular proliferation and colony formation, and led to cell apoptosis and cell cycle arrested in G2/M phase induced by X-radiation in vitro. In addition, tumor xenograft studies suggested that XRCC2 silencing inhibited tumorigenicity after radiation treatment in vivo. Our data suggest that the suppression of XRCC2 expression rendered colon tumor cells more sensitive to radiation therapy in vitro and in vivo, implying XRCC2 as a promising therapeutic target for the treatment of radioresistant human colon cancer.Keywords
This publication has 23 references indexed in Scilit:
- The importance of XRCC2 in RAD51-related DNA damage repairDNA Repair, 2010
- Breast cancer risk and common single nucleotide polymorphisms in homologous recombination DNA repair pathway genes XRCC2, XRCC3, NBS1 and RAD51Cancer Epidemiology, 2010
- Worldwide Variations in Colorectal CancerCA: A Cancer Journal for Clinicians, 2009
- Association of Polymorphisms in Genes of the Homologous Recombination DNA Repair Pathway and Thyroid Cancer RiskThyroid®, 2009
- Genetic Variants inXRCC2: New Insights Into Colorectal Cancer TumorigenesisCancer Epidemiology, Biomarkers & Prevention, 2009
- The interaction profile of homologous recombination repair proteins RAD51C, RAD51D and XRCC2 as determined by proteomic analysisProteomics, 2009
- A Comparison of Colon and Rectal Somatic DNA AlterationsDiseases of the Colon & Rectum, 2009
- Meta Association of Colorectal Cancer Confirms Risk Alleles at 8q24 and 18q21Cancer Epidemiology, Biomarkers & Prevention, 2009
- Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association ConsortiumBritish Journal of Cancer, 2009
- Role of cell cycle in mediating sensitivity to radiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004